![](/img/cover-not-exists.png)
CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
Morishima, Chihiro, McNeel, Douglas G, Patel, Manish R, Kohrt, Holbrook E, Waldmann, Thomas A, Thompson, John A, Conlon, Kevin C, Sondel, Paul M, Wakelee, Heather A, Apodaca, Minjun C, Fling, Steven PVolume:
3
Year:
2015
Language:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/2051-1426-3-S2-P203
File:
PDF, 253 KB
english, 2015